Venous thromboembolism (VTE), is major source of morbidity and mortality in cancer patients.

​

Incidence rates of cancer-associated thrombosis (CAT) vary with cancer type, stage, treatment, and comorbidities, but it is estimated that approximately 15-20 % of cancer patients will develop a venous thromboembolic episode at some point during the course of their illness.

​

-----

​

Presentation:

Gerald A Soff MD

Date: August 22, 2020